Oseltamivir phosphate-Lifting the restriction on its use to treat teenagers with influenza in Japan

Severe abnormal behavior incidence after administration of neuraminidase inhibitors using the national database of medical claims

(2018) Yuuki Nakamura et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?

(2017) Wakaba Fukushima et al.   VACCINE

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

(2015) Joanna Dobson et al.   LANCET

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

(2014) T. Jefferson et al.   BMJ-British Medical Journal

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010

(2012) Sharon K. Greene et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Oseltamivir and Abnormal Behavior

(2010) Michael M. Peng et al.   EPIDEMIOLOGY

Oseltamivir and Abnormal Behaviors

(2009) Takashi Yorifuji et al.   EPIDEMIOLOGY

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment

(2009) J. R. Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

INFLUENZA-ASSOCIATED CENTRAL NERVOUS SYSTEM DYSFUNCTION IN TAIWANESE CHILDREN

(2009) Yhu-Chering Huang et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL